"Doxazosin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
| Descriptor ID |
D017292
|
| MeSH Number(s) |
D03.633.100.786.750.200
|
| Concept/Terms |
Cardura- Cardura
- Cardular
- Zoxan
- Carduran
Doxazosin Mesylate- Doxazosin Mesylate
- Mesylate, Doxazosin
- 1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine
Doxazosin-ratiopharm- Doxazosin-ratiopharm
- Doxazosin ratiopharm
- ratio-Doxazosin
- ratio Doxazosin
- Doxazosina Ratiopharm
- Ratiopharm, Doxazosina
|
Below are MeSH descriptors whose meaning is more general than "Doxazosin".
Below are MeSH descriptors whose meaning is more specific than "Doxazosin".
This graph shows the total number of publications written about "Doxazosin" by people in this website by year, and whether "Doxazosin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Doxazosin" by people in Profiles.
-
Macoska JA, Uchtmann KS, Leverson GE, McVary KT, Ricke WA. Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the MTOPS Study. J Urol. 2019 12; 202(6):1240-1247.
-
Wilson TA, Foxall TL, Nicolosi RJ. Doxazosin, an alpha-1 antagonist, prevents further progression of the advanced atherosclerotic lesion in hypercholesterolemic hamsters. Metabolism. 2003 Oct; 52(10):1240-5.